Arcadia Investment Management Corp Castle Biosciences Inc Transaction History
Arcadia Investment Management Corp
- $623 Million
- Q4 2024
A detailed history of Arcadia Investment Management Corp transactions in Castle Biosciences Inc stock. As of the latest transaction made, Arcadia Investment Management Corp holds 904 shares of CSTL stock, worth $25,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
904Holding current value
$25,990% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
202Shares Held
26.2MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$87.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$52.5 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$50.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$41.3 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$36.3 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $756M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...